Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
15,435,572
-
Share change
-
+3,319,149
-
Total reported value
-
$248,886,000
-
Price per share
-
$16.17
-
Number of holders
-
55
-
Value change
-
+$55,421,873
-
Number of buys
-
34
-
Number of sells
-
22
Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q3 2021
As of 30 Sep 2021,
Vincerx Pharma, Inc. - Common Stock (VINC) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,435,572 shares.
The largest 10 holders included
SAGE RHINO CAPITAL LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Rubric Capital Management LP, TANG CAPITAL MANAGEMENT LLC, Affinity Asset Advisors, LLC, Rock Springs Capital Management LP, Holocene Advisors, LP, RTW INVESTMENTS, LP, BlackRock Inc., and SPHERA FUNDS MANAGEMENT LTD..
This page lists
55
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.